
Keywords: از دست دادن حجم مغز; AHSCT; autologous hematopoietic stem cell transplant; ARR; annualized relapse rate; BVL; brain volume loss; DMT; disease-modifying therapy; EDSS; Expanded Disability Status Scale; GA; glatiramer acetate; HRQoL; health-related quality of life; IFN; interfe